April/May 2015

Have you noticed a sharp uptick in merger and acquisition activity in radiology?

Becoming a value-driven partner to hospital clients in the challenging quest to remake healthcare is the best insurance against commoditization. 

With reimbursement for low-dose CT lung cancer screening assured, radiology will be called on to play an important role in the development and operation of screening programs.

Researchers have interrogated the DRG database to come up with initial targets for help with negotiating bundled payments.

A breast imager offers the subspecialty as a model for radiology’s transition from volume to value.

Imagine (or recall) a time when CT technology was a nascent science, MR units were at best shared between hospitals and often when performed the images were physically shipped to national experts for overnight reading.

If you’ve ever wondered if your current methodology for managing performance review is effective, you are not alone.

Physician practices increasingly are affiliating or merging with other practices or aligning with or being acquired by hospitals in order to better support the investments needed to successfully implement alternative payment models, according to a new RAND report released in March.

Last summer brought something of a media moment for mammography in the U.S. The spotlight shone on the star—3-D imaging for breast-cancer screening—after the Journal of the American Medical Association published a study showing that tomosynthesis, when added to digital mammography, is a natural at catching invasive cancers while exposing false positives as impostors.

With the SGR in the rear-view mirror, organized medicine weighed in on the historic overhaul of the Medicare physician payment system.